|
Archive 2007
Décision du CEPMB à l’égard du Dovobet
Publication de l’édition de juillet de La Nouvelle du CEPMB et annonce d’une nouvelle audience
Publication du rapport annuel 2006 du CEPMB
Engagement de conformité volontaire signé par Eli Lilly/L’Observateur des médicaments émergents du CEPMB
Marché des médicaments dont le brevet est récemment arrivé à échéance (rapport du CEPMB)
Communiqué du CEPMB (28 juin 2007) au sujet du calcul du PTM pour la période de rapport de janvier à juin 2007
Engagement de conformité volontaire à l'égard du Risperdal Consta et autres mises à jour au sujet du CEPMB
Nouvelles importantes : Rappel de la présentation de données requise en juillet 2007
Consultation au sujet des Lignes directrices du CEPMB sur les prix
Conclusion de l'audience visant l'Airomir par un engagement de conformité volontaire et autres mises à jour au sujet du CEPMB
April 2007 PMPRB Newsletter Released!
Le président et la directrice exécutive du CEPMB devant le Comité permanent de la santé, le 28 mars 2007
Décision de la Cour fédérale au sujet du Dovobet
Le CEPMB émet deux (2) nouveaux avis d'audience
Sommaire de l'édition de janvier du bulletin d'information La Nouvelle du CEPMB
Lancement de la politique québécoise du médicament
Mises à jour des listes 2007
Posted January 10, 2008
Nova Scotia
NS Pharmacare Bulletin, Vol.07-11 December 2007
Highlights
Change in Criteria for Clopidogrel, New Special MAC: Losec 10mg Tab;
New Products: Aranesp 200mcg/ml syringe; Ciprodex Otic Susp; Hepsera 10mg Tab; Humalog Mix50 Cartridges; Raptiva 150mg/vial Inj; Prevacid FasTab 15mg Tab; Sativex Spray; Zytram XL 150mg, 200mg, 300mg, 400mg Tab.
Interchangeable products: Novo-Rabeprazole EC 10mg, 20mg EC Tab; Pariet 10mg, 20mg EC Tab; New Diabetic Products: TrueTrack Blood Glucose Test Strips - 50/box & 100/box; Sidekick Blood Glucose Testing System.
Posted December 28, 2008
Nova Scotia
NS Pharmacare Bulletin, Vol 07-12, December 2007
Highlights
Benefit Status Change for Omeprazole and Rabeprazole: Apo-Omeprazole 20mg Cap; Lose 20mg Cap, Losec 10mg Tab; Losec 20mg Tab; ratio-Omeprazole 20mg Tab; Sandoz Omeprazole 20mg Cap; Pariet 10mg EC Tab; Pariet 20mg EC Tab; Novo-Rabeprazole EC 10mg, 20mg Tab. These products have changed from Exception status to FB when prescribed at the standard dose of 20mg daily.
Posted December 19, 2007
Québec
Quebec Communique, Modification #4 a la Liste de medicaments, effective Dec 19, 2007
Highlights
Exception Drug addition of new indication for payment and new criteria: Sprycel 20mg, 50mg, 70mg Tabs
Posted December 10, 2007
Ontario
ODB Edition 40, Update D7 effective Dec 19, 2007
Highlights
New Multi-Source Drugs: Apo-Enalapril 2.5mg, 5mg, 10mg, 20mg Tab; Co Enalapril 2.5mg, 5mg, 10mg, 20mg Tab; Co Lisinopril 5mg, 10mg, 20mg Tab; Co Ramipril 2.5mg, 5mg Tab; Gen- Enalapril 2.5mg, 5mg, 10mg, 20mg Tab; Gen-Lisinopril 5mg, 10mg, 20mg Tab; Novo-Lisinopril (Type P) 5mg, 10mg, 20mg Tab; Novo-Lisinopril (Type Z) 5mg, 10mg, 20mg Tab; PMS-Lisinopril 5mg, 10mg, 20mg Tab; Ran-Lisinopril 5mg, 10mg, 20mg Tab; Ran-Tamsulosin 0.4mg Cap; ratio-Enalapril 2.5mg, 5mg, 10mg, 20mg Tab; Ratio-Lisinopril P 5mg, 10mg, 20mg Tab; Ratio-Lisinopril Z 5mg, 10mg, 20mg Tab; Sandoz Enalapril 2.5mg, 5mg, 10mg, 20mg Tab; Sandoz Lisinopril P 5mg, 10mg, 20mg Tab; Sandoz Lisinopril Z 5mg, 10mg, 20mg Tab;
Drug Benefit Prices: Apo-Cilazapril/HCTZ 5mg/12.5mg Tab; Apo-Digoxin 0.0625mg Tab; Atacand 8mg, 16mg tab; Atacand Plus 16mg/12.5mg Tab; Halog 0.1% Oint;
Status Changes From Not-A-Benefit To General Benefit: Apo-Lisinozide 10mg & 12.5mg Tab:
Trade Name Changes: Apo-Lisinopril HCTZ 10mg & 12.5mg Tab;
New Diabetic Testing Agents: True Track Smart System Strips;
Off Formulary Interchangeable Products: Apo-Cetirizine 10mg Tab; Apo-Loratadine 10mg Tab; Apo-Napro-Na 275mg Tab; Apo-Napro-Na DS 550mg Tab; Apo-Sotalol 80mg Tab; Apo-Terbinafine 250mg Tab; Co Levetiracetam 250mg, 500mg, 750mg Tab; Co Metformin 850mg Tab; Co Sotalol 80mg Tab; Co Terbinafine 250mg Tab; Cyestra-35 2mg & 0.035mg Tab; Gen-Sotalol 80mg Tab; Gen-Terbinafine 250mg Tab; Novo-Sotalol 80mg Tab; Novo-Terbinafine 250mg Tab; PMS-Sotalol 80mg Tab; Ratio-Metformin 850mg Tab; Ratio-Sotalol 80mg Tab; Sandoz Metformin FC 850mg Tab; Sandoz Sotalol 80mg Tab; Sandoz Terbinafine 250mg Tab.
Posted December 10, 2007
British Columbia
BC Pharmacare Newsletter Edition 07-009, effective Dec 7, 2007
Highlights
Benefits: Humalog Mix 50 100u/ml Cartridge; Novomix 30 100 u/ml. Eligible for Plans C & F Life Brand Blood Glucose Test Strips; Limited Coverage by Special Authority Humira 40mg/0.8ml for the treatment of psoriatic arthritis. Non Benefits: Ezetrol 10mg Tab
Posted December 10, 2007
Alberta
Additions to the AHWDBL effective Dec 1, 2007
Highlights
Additions: Co enalapril 2.5mg, 5mg, 10mg, 20mg Tab; Gen-Enalapril 2.5mg, 5mg, 10mg, 20mg; Ratio-Enalapril 2.5mg, 5mg, 10mg, 20mg; Sandoz Enalapril 2.5mg, 5mg, 10mg, 20mg; Co Lisinopril 5mg, 10mg, 20mg Tab; Gen-Lisinopril 5mg, 10mg, 20mg Tab; Novo-Lisinopril (Type P) 5mg, 10mg, 20mg Tab; Novo-Lisinopril (Type Z) 5mg, 10mg, 20mg Tab; Ran-Lisinopril 5mg, 10mg, 20mg Tab; Ratio-Lisinopril P 5mg, 10mg, 20mg Tab; Ratio-Lisinopril Z 5mg, 10mg, 20mg Tab; Sandoz Lisinopril 5mg, 10mg, 20mg Tab
Posted December 6, 2007
Newfoundland
NLPDP - Prescription Drug Program Bulletin 51, December 2007
Highlights
Status effective January 1, 2008: Apo-Benazepril 5mg, 10mg Tab; Novo-Olanzapine 2.5mg, 5mg, 7.5mg, 10mg, 15mg Tab; Ran-Cefprozil 250mg, 500mg Tab; Apo-Cefprozil 250mg, 500mg Tab; Apo-Cefprozil 125mg/5ml, 250mg/5ml O/Susp ; Ran-Cefprozil 250mg/5ml O/Susp; Portia 21, 28 Tab; Ratio-Fluticasone Aqueous Spray 50mcg/metered dose; Apo-Enalapril 2.5mg, 5mg, 10mg, 20mg Tab; Novo-Sumatriptan DF 25mg, 50mg, 100mg Tab; Gen-Sumatriptan 25mg, 50mg, 100mg Tab; Gen-Zopiclone 5mg Tab; Gen-Ondansetron 4mg, 8mg Tab; Gen-Tamsulosin 0.4mg Cap SR; Sandoz Tamsulosin 0.4mg Cap SR; Co Topiramate 25mg, 100mg, 200mg Tab; Ran-Pravastatin 10mg, 20mg, 40mg Tab; Ratio-Venlafaxine XR 37.5mg, 75mg, 150mg Cap; Sandoz Ramipril 1.25mg, 2.5mg, 5mg, 10mg Tab; Co Ramipril 1.25mg, 2.5mg, 5mg, 10mg Cap; pms-Levetiracetam 250mg, 500mg, 750mg Tab; Apo-Glimepiride 1mg, 2mg, 4mg Tab; Novo-Fenofibrate-S 100mg, 160mg Tab; Apo-Brimonidine 0.2% Oph Sol; Novo-Citalopram 20mg Tab; pms-ASA EC 325mg Tab.
Posted December 5, 2007
Nova Scotia
NS Pharmacare Bulletin Vol #07-10, November 2007
Highlights
New Ostomy Products: 41 New products see list for details.
New Products: Sandoz Lisinopril 5mg, 10mg, 20mg.
Interchangeable Products Added: pms-ASA EC 325mg Tab; RAN-Atenolol 50mg tab; Novo-Citalopram 20mg Tab; RAN-Citalo 20mg, 40mg Tab; Novo-Desmopreessin 0.1mg, 0.2mg Tab; pms-Digoxin 0.0625mg Tab; Apo-Glimepiride 1mg, 2mg, 4mg Tab; Apo-Lisinopril 5mg, 10mg, 20mg Tab; CO-Lisinopril 5mg, 10mg, 20mg Tab; Gen-Lisinopril 5mg, 10mg, 20mg Tab; Novo-Lisinopril P 5mg, 10mg, 20mg Tab; Novo-Lisinopril Z 5mg, 10mg, 20mg Tab; pms-Lisinopril 5mg, 10mg, 20mg Tab; RAN-Lisinopril 5mg, 10mg, 20mg Tab; ratio-Lisinopril P 5mg, 10mg, 20mg Tab; ratio-Lisinopril Z 5mg, 10mg, 20mg Tab; Sandoz Omeprazole 20mg Cap; ratio-Omeprazole 20mg Cap/Tab; Gen -Ondansetron 4mg, 8mg Tab; Sandoz Ramipril 1.25mg, 2.5mg, 5mg, 10mg Cap/Tab; Gen -Tamsulosin 0.4mg Cap; CO Topiramate 25mg, 100mg, 200mg Tab; ratio-Venlafaxine XR 37.5mg, 75mg, 150mg Cap; Gen-Zopiclone 5mg Tab.
Posted November 21, 2007
Québec
Quebec Capsule Nov 2007
Highlights
Addition: Lucentis 10mg/ml Inj Sol.
Posted November 16, 2007
Ontario
ODB Edition No 40, Update 6A, effective Nov 16, 2007
Highlights
Addendum to Notices of Oct 31, 2007 and Nov 8, 2007. Added to off formulary interchangeability: Apo-Buspirone 10mg Tab, PMS_buspirone 10mg Tab
Posted November 14, 2007
Newfoundland
NLPDP Bulletin No 48, Nov 5, 2007
Highlights
New Categories Effective January 05, 2008: Apo-Benazepril 5mg, 10mg Tab; Lotesin 5mg, 10mg Tab; Novo-Olanzapine 2.5mg, 5mg, 7.5mg, 10mg, 15mg Tab; Zyprexa 2.5mg, 5mg, 7.5mg, 10mg, 15mg Tab;Ran-Cefprozil 250mg, 500mg Tab; 250mg/5ml Orl Susp; Apo-Cefprozil 250mg, 500mg Tab; 125mg/5ml, 250mg/5ml Orl Susp; Cefzil 250mg, 500mg, Tab; 125mg/5ml, 250mg/5ml Orl Susp; Portia 21,28 Tab; Min-Ovral 21, 28 Tab; ratio-Fluticasone Spray; Flonase Spray; Apo-Enalapril 2.5mg, 5mg, 10mg, 20mg Tab; Vasotec 2.5mg, 5mg, 10mg, 20mg Tab; Novo-Sumatriptan DF 25mg, 50mg, 100mg Tab; Gen-Sumatriptan 25mg, 50mg, 100mg Tab; Imitrax DF 25mg, 50mg, 100mg Tab;
Additions To Existing Categories: Gen-Zopiclone 5mg Tab, Gen-Ondansetron 4mg, 8mg Tab; Gen-Tamsulosin 0.4mg Cap SR; Sandoz Tamsulosin 0.4mg Cao SR; Co Topiramate 25mg, 100mg, 200mg Tab;Ran-Pravastatin 10mg, 20mg, 40mg Tab; Ratio-Venlafaxine XR 37.5mg, 75mg, 150mg Cap; Sandoz Ramipril 1.25mg, 2.5mg, 5mg, 10mg Tab; Co Ramipril 1.25mg, 2.5mg, 5mg, 10mg Cap; pms-Levetiracetam 250mg, 500mg, 750mg Tab; Apo-Glimepiride 1mg, 2mg, 4mg Tab; Novo-Fenofibrate-S 100mg, 160mg Tab; Apo-Brimonidine 0.2% Oph Sol; Novo-Citalopram 20mg Tab; pms-ASA EC 325mg Tab.
Posted November 14, 2007
Saskatchewan
Saskatchewan Pharmacy Information Bulletin #428, Oct 31, 2007
Highlights
New Generics: Apo-Citalopram 80mg/11.4mg/ml Oral Susp; Novo-Citalopram 20mg Tab; Apo-Enalapril 2.5mg, 5mg, 10mg, 20mg Tab; Co-Enalapril 2.5mg, 5mg, 10mg, 20mg Tab; Gen-Enalapril 2.5mg, 5mg, 10mg, 20mg Tab; Novo-Enalapril 2.5mg, 5mg, 10mg, 20mg Tab; pms-Enalapril 2.5mg, 5mg, 10mg, 20mg Tab; ratio-Enalapril 2.5mg, 5mg, 10mg, 20mg Tab; Sandoz Enalapril 2.5mg, 5mg, 10mg, 20mg Tab; Novo-Enalapril/HCTZ 5mg/12.5mg, 10mg/25mg Tab; Apo-Lisinopril 5mg, 10mg, 20mg Tab; Co-Lisinpril 5mg, 10mg, 20mg Tab; Gen-Lisinopril 5mg, 10mg, 20mg Tab; Novo-Lisinopril (Type P) 5mg, 10mg, 20mg Tab; Novo-Lisinopril (Type Z) 5mg, 10mg, 20mg Tab;pms-Lisinopril 5mg, 10mg, 20mg Tab; Ran-Lisinopril 5mg, 10mg, 20mg Tab;Ratio-Lisinopril P 5mg, 10mg, 20mg Tab; Ratio-Lisinopril Z 5mg, 10mg, 20mg Tab; Sandoz Lisinopril 5mg, 10mg, 20mg Tab; Apo-Lisinopril/HCTZ 10mg/12.5mg Tab; Apo-Lithium Carbonate SR 300mg SR Tab; Sandoz Omeprazole 10mg, 20mg Cap; Co Ramipril 1.25mg, 2.5mg, 5mg, 10mg Cap; Sandoz Ramipril 1.25mg, 2.5mg, 5mg, 10mg Cap; Ran-Tamsulosin XR 0.4mg SR Cap; pms-Venlafaxine XR 37.5mg, 75mg, 150mg Cap.
Posted November 14, 2007
Newfoundland
NLPDP - Notice to pharmacies Bulletin 47, November 2007
Highlights
Launch of the Assurance Plan. New Plan Names.
Posted November 14, 2007
Newfoundland
NLPDP Behind the Scenes Bulletin Fall 2007
Highlights
New Categories Effective July 01, 2007: Bupropion Hydrochloride SR 100mg, 200mg; Felodipine ER 5mg, 10mg Tab; Pramipexole 0.25mg, 0.5mg, 1mg, 1.5mg Tab; Venlafaxine XR 37.5mg, 75mg, 150mg Cap; Hydrocortisone Acetate 0.5%; Pramoxine HCL 1%; Zinc Sulfate 0.5% Rectal Ointment; Digoxin 0.0625mg; 0.125mg, 0.25mg Tab; Omeprazple 20mg DR tab; Ramipril 1.25mg, 2.5mg, 5mg, 10mg Cap;
Changes To The NLPDP Benefit Listing: Nwe Open benefit For Income Support, Low Income and Senior's Drug Plans: Sodium Aurothiomalate 10mg, 25mg, 50mg; Altace 15mg; Altace HCT 2.5/12.5mg, 5/12.5mg; 10/12.5mg, 5/25mg, 10/25mg; Pms-dexamethasone 2mg, DDAVP 60mcg, 120mcg, melts.
New Open Benefits For Income Support/Low income Drug Plans: Linessa 28's, 21's;
Special Authorization: Avalide 300/25mg; Duragesic 12mcg; Orencia 250mg; Pariet 20mg; Prezista 300mg(for HIV); Rebif Initiation Pack; Revatio 20mg(for PAH); Rituxan 10mg/ml(for RA); Sutent 12.5mg, 25mg, 50mg; Biphentin(for ADHD) 10mg, 15mg, 20mg, 30mg, 40mg, 50mg, 60mg; Kaletra 200/50mg; Humira 40mg(for AS); Tracleer 62.5MG, 125MG.
Medications Not Considered For Coverage: Naxavar 200mg; Denavir 1% Cream; Tramacet 325/37.5mg; Tysabri; Azilect 0.5mg, 1.0mg; Vantas 50mg.
Medications Not Considered For Coverage under the NLPDP: Concerta 18mg, 27mg, 36mg, 54mg; Betaseron; Cosopt PF; Trusopt PF; Enbrel 25mg, 50mg.
Posted November 14, 2007
Alberta
Alberta Additions effective Nov 1, 2007
Highlights
New Drug Products Added to the AHWDBL: Losec (Capsule) 20mg Oral Capsule/Sustained Release Tablet; Ratio-Venlafaxine XR 37.5mg, 75mg, 150mg (Base) Oral Extended- Release Capsule. Change in Special Authorization Criteria: Telithromycin 400mg Oral Tab.
Posted November 7, 2007
Québec
Modification No. 2, Liste de medicaments - effective Nov 7, 2007
Highlights
Additions: Apo-Enalapril 2.5mg, 5mg, 10mg, 20mg Tabs; Novo-Olanzapine 2.5mg, 5mg, 7.5mg, 10mg, 15mg Tabs
Posted November 5, 2007
New Brunswick
NBPDP Bulletin #698, November 5, 2007
Highlights
Regular Benefit Additions: pms-Citalopram 10mg Orl; Hyoscine Butylbromide 20mg/ml Inj; Lorazepam 4mg/ml Inj; Apo-Methylphenidate 5mg Orl; Midazolam 1mg/ml, 5mg/ml Inj; Altace HCT 2.5mg/12.5mg, 5mg/12.5mg, 5mg/25mg, 10mg/12.5mg, 10mg/25mg Orl; Invirase 500mg Orl.
No Longer Require Special Authorization: Arimidex 1mg Orl; Aromasin 25mg Orl; Femara 2.5mg Orl.
Special Authorization Additions: Orencia 250mg vial IV Inj; Uromax 10mg, 15mg controlled release tablet.
Special Authorization - Revised Criteria: Fragmin 25,000IU/ml multidose vial; 25,000IU/ml prefilled syringe; Lovenox 100mg/ml multidose vial; Fraxiparin 19,000IU/ml prefilled syringe; Innohep 10,000IU/ml, 20,000IU/ml multidose vial, 20,000IU/ml prefilled syringe.
Drugs Reviewed And Not Listed: PhosLo 667mg Tab; Zyprexa 10mg vial for IM Inj; Tramacet 37.5mg/325mg Tab.
Posted November 1, 2007
Ontario
ODB Edition 40, Update 6 effective Nov 9, 2007
Highlights
New Single Source Drug(s): NovoMix 30 Penfill 100U/ml Inj Susp-5x3ml Pk; Wellbutrin XL 150mg, 300mg Tab.
New Multi-Source Drug(s): Apo-Metoprolol SR 100mg, 200mg LA Tab; Co Ramipril 1.25mg, 10mg Cap; Novo-Citalopram 20mg Tab; PMS-Digoxin 0.0625mg Tab; PMS-Venalafaxine XR 37.5mg, 75mg, 150mg ER Cap; Sandoz Omeprazole 20mg Cap.
Drug Benefit Price Changes: Novo-Hydrazide 25mg, 50mg Tab; Novo-Venlafaxine XR 37.5mg, 75mg, 150mg ER Cap.
Not-A-Benefit Drug(s): Losec 20mg Cap.
Discontinued Drug(s) (Removed From Payment Listings): Apo-Levobunolol 0.25% Oph Sol; Apo-Sulfatrim 40mg & 8mg/ml O/L; Stieva-A 0.01% Gel.
Package Size Change: Pico-Salax 3.5g, 12g, 10mg Pd for Sol-2x12g Sachet Pk.
Product Identification Number: Apo-Omeprazole 20mg Cap.
Status Change(s) from 'Not-A-Benefit' to General Benefit: Apo-Lisinopril 5mg, 10mg, 20mg Tab;
Off Formulary Interchangeable Product(s): Apo-Etodolac 200mg, 300mg Cap; Apo-Fluticasone 50mcg/Actuation Nas Sp-120 Dose Pk; Apo-Glimepiride 1mg,2mg,4mg Tab; Apo-Levetiracetam 250mg, 500mg, 750mg Tab; Gen-Alendronate 5mg Tab; Gen-Buspirone 10mg Tab; Novo-Buspirone 10mg Tab; Ratio-Buspirone 10mg Tab; Ratio-Fluticasone 50mcg/Actuation Nas Sp-120 Dose Pk.
Posted October 30, 2007
Nova Scotia
NS Pharmacare Bulletin Vol #07-09, October 2007
Highlights
New Benefit - Losec Capsule: APO-Omeprazole 20mg Cap/Tab.
New Wound Care Products: 17 new products see list for details.
Posted October 29, 2007
New Brunswick
Benefit Changes to NBPDP; Bulletin# 696 October 12,2007
Highlights
NBPDP Benefit Additions: pms-ASA EC 325mg, 650mg Ect; Apo-Benazepril 5mg, 10mg Tab; Apo-Clarithromycin 250mg, 500mg Tab; Gen-Clarithromycin 250mg, 500mg Tab; pms-Claritromycin 250mg, 500mg Tab; ratio-Claritromycin 250mg, 500mg Tab; Apo-Desmopressin 0.1mg, 0.2mg Tab; Novo- Desmopressin 0.1mg, 0.2mg Tab; pms-Digoxin 0.0625mg Tab; pms-Doxycycline 100mg Tab, pms-Doxycycline 100mg Cap; ratio-Fluticasone 50mcg Aem; pms-Levetiracetam 250mg, 500mg, 750mg Tab; Portia 21 0.15mg/0.03mg Tab; Portia 28 0.15mg/0.03mg Tab; Apo-Metoprolol SR 100mg,200mg SRT; Octreotide Acetate Omega 0.05mg/ml, 0.1mg/ml, 0.2mg/ml, 0.5mg/ml Liq Inj; Novo-Olanzepine 2.5mg, 5mg, 7.5mg, 10mg, 15mg Tab;Sandoz-Omeprazole 20mg SRC; Ran-Pravastatin 10mg, 20mg, 40mg Tab; Sandoz-Ramipril 1.25mg, 2.5mg, 5mg, 10mg Tab; ratio-Venlafaxine XR 37.5mg, 75mg, 150mg SRC.
Non-Listed Products Subject to Map: Apo-Cefprozil 125mg/5ml, 250mg/5ml Pwr; Co Topiramate 25mg, 100mg, 200mg Tab
Posted October 22, 2007
Alberta
Additions to AHWDBL, effecive Oct 17, 2007
Highlights
New Intrerchangeable Products Affected by LCA Pricing: Apo-Enalapril 2.5mg, 5mg, 10mg, 20mg Tab; Apo-Lisinopril 5mg, 10mg, 20mg Tab
Posted October 22, 2007
Alberta
Additions to AHWDBL, effective Oct 12, 2007
Highlights
Interchangeable Products Affected by New LCA Pricing: Zantac 150mg, 300mg Tab; Apo-Ranitidine 150mg, 300mg Tab; Co-Ranitidine 150mg, 300mg; Gen-Ranitidine 150mg, 300mg Tab; Novo-Ranitidine 150mg, 300mg Tab; Nu-Ranit 150mg, 300mg Tab;Pms-Ranitidine 150mg, 300mg Tab; Ratio-Ranitidine 150mg, 300mg Tab; Sandoz Ranitidine 150mg, 300mg Tab
Posted October 10, 2007
British Columbia
BC Pharmacare Bulletin Edition 07-008, Oct 4, 2007
Highlights
Announcement of the Alzheimer's Drug Theraphy Initiative.
Posted October 10, 2007
Alberta
AHWDBL & AEIIDBS Quarterly updates Oct 1, 2007
Highlights
Added Products: Apo-Benazepril 5mg, 10mg Tab; Apo-Cefprozil 25mg/ml, 50mg/ml Oral Susp, Apo-Cefprozil 250mg, 500mg Tab;Apo-Cilazapril 1mg Tab;Apo-Pramipexole 0.25mg, 1mg, 1.5mg Tab; Ceftriaxone 1g/vial, 2g/vial Inj; Duo Trav 0.004%/0.5% Oph Sol;Novo-Acyclovir 200mg, 400mg, 800mg Tab; Novo-Atenolol 25mg Tab;Novo-Fenofibrate 100mg, 160mg Tab;Novo-Ramipril 1.25mg, 2.5mg, 5mg, 10mg Cap; Pms-ASA Ec 650mg ECT; Ran-Cefprozil 250mg, 500mg Tab;Ran-Cefprozil 50mg/ml Oral Susp;Ran-Prevastatin Sodium 10mg, 20mg, 40mg Tab; Ratio-Tamsulosin HCL 0.4mg SRC; Sandoz Risperidone 0.25mg Tab; Sandoz Tamsulosin HCL 0.4mg SRC.
Change in Status from Special Authorization to Unrestricted Product(s): Combigan 0.2% 0.5% (Base) Ophth Sol.
Deleted Listing: Famvir 500mg Tab; Herplex-D Liquifilm 0.1% Top Sol: Miostat 0.01% Oph Sol; Sandoz Idoxuridine 0.1% Top Sol; Zovirax 5% Top Sol.
Discontinued Listing(s): Clavulin-250 (Base) Tab; Fluotic 20mg ECT; Ortho-Cept (21 day) Tab; Parlodel 2.5mg Tab; Premarin 0.9mg Tab; Rocephin 2g/vial Inj.
Special Authorization: Xalacom 0.005%/0.5% Ophth Sol.
Change in Status from Unrestricted to Special Authorization: Lumigan 0.03% Oph Sol; Xalatan 0.005% Oph Sol.
Drug Product(s) with Changes to Criteria for Coverage: Aranesp 10mcg/0.4ml Inj; Aranesp 20mcg/0.5ml Inj; Aranesp 100mcg/ml, 200mcg/ml, 500mcg/ml Inj; Enbrel 25mg/vial Inj; Enbrel 50mg/ml Inj; Eprex 1,000unit/0.5ml, 2,000unit/0.5ml Inj; Eprex 10,000unit/ml, 20,000unit/ml, 40,000unit/ml Inj; Eprex 4,000unit/0.4ml Inj; Eprex 5,000unit/0.5ml Inj; Eprex 6,000unit/0.6ml Inj; Eprex 8,000unit/0.8ml Inj; Ezetrol 10mg Tab; Humira 40mg/0.8ml Inj; Kineret 100mg/syr Inj; Remicade 100mg/vial Inj.
Posted October 10, 2007
Ontario
Amended Formulary Edition No 40, Update 5 effective Oct 3, 2007
Highlights
Following changes were made to the Not a Benefit List: Apo-Lisinopril 10mg & 12.5mg Tab; Portia 21 and Portia 28
Posted October 2, 2007
Québec
Capsule & Full Formulary Release - Hard copy
Highlights
Additions: Advicor 500mg-20mg, 1000mg-20mg, 1000mg-40mg; Champix .5mg, 1mg Tab; cyclosporine 1% or 2%; Somatuline Autogel 60mg/0.3ml, 90mg/0.3ml, 120mg/0.5ml SC Inj Sol.
Status Change to Full Benefit: Amphojel 600mg Tab.
New Exception Medication Additions: Microlipid - Nutritional for babies; PegLyte 70g & 280g oral pd; Ventolin Diskus 200mcg pd for inh;
Exception Medication Indications added: Remicade 100mg IV.
Modifications to existing Criteria: Aranesp, Eprex, Dostinex 0.5mg Tab; Fuzeon 108mg Inj SC Pd; Aptivus, Prezista, Xeloda.
Declined due to therapeutic value: Adderall XR (for treatment of ADD in Adults); Fosavance 70mg-70mcg;
Declined due to price: Exjade 125mg, 250mg, 500mg Tab; Tramacet 37.5mg-325mg
Posted October 2, 2007
Prince Edward Island
PEI MAC List & Memorandum Sept 2007
Highlights
New Interchangeable / MAC Categories: Ethinyl Estradiol & L-Norestrel 0.03mg, 0.15mg Tab (21 Day); Ethinyl Estradiol & L-Norgestrel 0.03mg, 0.15mg Tab (28 Day).
Products Added to the Interchangeable / MAC List: Co Topiramate 25mg, 100mg, 200mg Tab; PMS-Clarithromycin 250mg, 500mg Tab; Ratio-Venlafazine XR 37.5mg, 75mg, 150mg Extended Release Capsule.
Discontinued Products: Sandoz-Valproic 500mg ENT Cap. Changes in Manufacturer: Methotrexate 2.5mg Tab; Pamidronate Disodium 30mg, 90mg Inj.
Posted October 2, 2007
New Brunswick
NBPDP Full Formulary Sept 2007
Highlights
Full formulary release.
Posted October 2, 2007
Saskatchewan
Saskatchewan Bulletin #112 Oct 2007
Highlights
New Full Formulary Listings: Ascensia Breeze 2, Resultz 50% Top Sol; Altace HCT 2.5mg/12.5mg, 5mg/12.5mg, 10mg/12.5mg, 5mg/25mg, 10mg/25mg Tab; Diovan 320mg Tab.
New EDS Listings: Orencia 25mg/vial; Somatuline Autogel 60mg, 90mg, 120mg Syringe; Rituxan 10mg/ml Inj;
New Strenghts/Dosage/Forms Of Currently Listed EDS Drugs: Reyataz 300mg Cap.
Drugs Listed Will Be Approved Under EDS For Additional Criteria: Fosamax 70mg/75ml Orl Sol; Plavix 75mg Tab;
Revised EDS Criteria: Symbicort 6mcg/100mcg, 6mcg/200mcg;
Under Review With National CDR Process: Humira, Sativex, Baraclude, Elaprase, Fosrenol, Spriafil, Lucentis, Thelin, Sebivo, Zytram XL.
Other Products Currently Under Review By The Saskatchewan Review Committees: Myozyme 50mg/vial PWS; Raptiva 150mg/vial PWS; Enbrel 25mg/vial, 50mg/vial pre-filled Inj; Remicade 100mg/vial Inj; Tysabri 300mg/ml Inj Sol;
Products Not recomended For Coverage Via CDR: Prexige 100mg Tab; Denavir 1% Cre; Tramacet 37.5mg/325mg Tab;
Products Not Recomended By The Saskatchewan Review Committees: Humira 40mg/0.8ml Inj; Trusopt 2% Oph Sol; Diamicron 30mg Tab; Remicade 100mg/vial Inj; Biphentin 10mg, 15mg, 20mg, 30mg, 40mg, 50mg, 60mg Cap; Zyprexa 20mg Tab; Humira 40mg/0.8ml Syr; Enbrel 25mg/vial, 50mg/vial Syr; Remicade 100mg/vial Inj;
New Interchangeable Listings Effective July 01, 2007: pms-ASA 650mg EC Tab; ratio-Fluticasone 50mcg Nas Spray; pms-Levetiracetam 250mg, 500mg, 750mg Tab; Ran-Pravastatin 10mg, 20mg, 40mg Tab; Sandoz Tamsulosin 0.4mg ER Tab.
New Interchangeable EDS Listings Effective August 01, 2007 According To Current EDS Criteria: Apo-Cefprozil 25mg/ml, 50mg/ml Susp; Apo-Clarithromycin 250mg, 500mg Tab; Gen-Clarithromycin 250mg, 500mg Tab; pms-Clarithromycin 250mg, 500mg Tab; Rati-Clarithromycin 250mg, 500mg Tab.
New Interchangeable Listings Effective August 01, 2007: Apo-Benazepril 5mg, 10mg, Tab; pms-Doxycycline 100mg Tab & Cap;
New Interchangeable Listings Effective September 01, 2007: pms-ASA 325 EC Tab; Apo-Metoprolol SR 100mg, 200mg ER Tab; CO Topirimate 25mg, 100mg, 200mg Tab.
New Interchangeable EDS Listings Effective September 01, 2007 According To Current EDS Criteria: Novo--Desmopressin 0.1mg, 0.2mg Tab;
New Interchangeable EDS Listings Effective October 01, 2007: Gen-Tamsulosin 0.4mg ER Tab; ratio-Venlafaxine 37.5mg, 75mg, 150mg ER Tab.
Posted September 27, 2007
Ontario
ODB Edition 40, Update 5, Effective October 3, 2007
Highlights
New Multisource Drugs: Apo-Benazepril 5mg, 10mg Tab; Apo-Lisinozide 10mg & 12.5mg Tab; Co-Topiramate 25mg, 100mg, 200mg Tab; Gen-Tamsulosin 0.4mg Cap; PMS-Clarithromycin 250mg Tab; PMS-Ofloxacin 0.3% Oph Sol; Portia 21 0.03mg & 0.15mg, Portia 28 0.03mg & 0.15mg; Ratio-Venlafaxine XR 37.5mg, 75mg, 150mg ER Cap;
Manufacturer Requested Discontinued Drugs: Tofranil 25mg Tab; Triphasil 21 3 Phase 21Pk Tab; Triphasil 28 3 Phase 28Pk Tab.
Delisted Drugs: Boost Plus Calories 237 Ml Pk Liq; Cliticare HN 235 Ml Pk Liq; Isocal 250ml Pk Liq; Isocal With Fibre 250ml Pk Liq; Permax 0.05mg, 0.25mg, 1mg Tab; Subdue 237ml Pk Liq.
New Drug Benefit Prices: Apo-Desmopressin 0.1mg, 0.2mg Tab; Apo-Hydro 25 25mg Tab, Apo-Hydro 50 50mg Tab;
Not A Benefit Drugs: Altrovent 250mcg/ml Inh Sol; Altrovent UDV 125mcg/ml, 250mcg/ml Inh Sol.
Discontinued Drugs Removed From Payment & Listing: Berotec Inh Pd 200 Dose Pk; Berotec Inh 0.1% Inh Sol; PMS-Ticlopidine 250mg Tab; Vaponefrin 2.25% Inh Sol.
Off Formulary Intechangeable Products: Apo-Alendronade 5mg Tab; Apo-Clarithromycin 500mg Tab; Gen-Clarithromycin 500mg Tab; Gen-Verapamil SR 120mg LA Tab; Novo-Alendronate 5mg Tab; PMS-Clarithromycin 500mg Tab; PMS-Famciclovir 125mg, 250mg Tab; PMS- Pramipexole 0.5mg Tab; Ratio-Clarithromycin 500mg Tab; Sandoz Alendronate 5mg Tab.
Posted September 19, 2007
NIHB
Updates to Drug Benefit List - Fall 2007
Highlights
Open Benefits-Single-Source Drug Products-Effective Fall 2007: Altace HCT 2.5mg/12.5mg, 5mg/12.5mg, 5mg/25mg, 10mg/12.5mg, 10mg/25mg Tab; Buscopan 10mg; Diovan 320mg Tab; Lovenox 100mg/ml Inj; Reyataz 150mg, 200mg, 300mg Cap.
Multi-Source Drug Products-Open Benefits: 48 Products Added-See List For Details.
New Limited Use Benefits: Tarceva 100mg, 200mg Tab; Proscar 5mg Tab; Gleevec 400mg Tab; Demerol 50mg Tab; Oxycontin 5mg Controled Release Tab; Sutent 12.5mg, 25mg, 50mg Cap; Sandoz Alendronate 5mg, 10mg, 70mg Tab; Ratio-Bupropion SR 100mg, 150mg Tab; PMS-Leflunomide 10mg, 20mg Tab; PMS-Levetiracetam 250mg, 500mg, 750mg Tab; Ratio-Tamsulosin 0.4mg ER Cap; Sandoz-Tamsulosin 0.4mg ER Cap;
Changes In Benefit: Proscar 5mg Tab.
No Longer Limited Use: Demerol 50mg Tab; Reyataz 150mg, 200mg, 300mg Cap;
Removed From Formulary: Apo-Chlordiazepoxide 10mg, 25mg, 5mg; Apo-Clorazepate 15mg, 3.75 mg, 7.5mg; Apo-Flurazepam 15mg, 30mg Cap; Dalmane 15mg, 30mg Cap; Flurazepam 15mg Cap; Novo-Clopate 15mg, 3.75mg, 7.5mg Cap; PDL-Chlordiazepoxide 10mg, 25mg; PDL-Flurazepam 30mg Cap; Somnol 15mg, 30mg Tab;
Not Added To Formulary: Azilect 0.5mg, 1mg Tab; Denavir 1% Crm; Exjade 125mg, 250mg, 500mg Tab; Tramacet 37.5mg/325mg Tab; Tysabri 300mg/15ml Inj; Vantas 50mg Inj.
Drugs Discontinued By The Manufacturer: Novo-Levofloxacin 250mg, 500mg Tab; Ortho-Cept 21 Tab; Parlodel 2.5mg Tab; Permax 0.05mg, 0.25mg, 1mg Tab; Premarin 0.9mg Tab;
Posted September 6, 2007
New Brunswick
Benefit changes to NBPDP, Bulletin #692, Aug 31, 2007
Highlights
Regular Benefit Additions: Desferal, pms-defoxamine, Desferrioxamine 500mg Inj PWS; Desferal, Desferrioxamine 2g Inj PWS; Twinject 0.15mg, 0.3mg Inj Liq; Avonex PS 30mcg/0.5ml Inj Liq; Lopresor SR 100mg, 200mg Orl SRT; Saizen 8.8mg Inj PWS; Apo-Sotalol, Co Sotalol, Gen-Sotalol, Nu-Sotalol, Novo-Sotalol, pms-Sotalol, Rhoxal-Sotalol, Sandoz Sotalol 80mg Tab.
Special Authorization Additions: Exjade 125mg, 250mg, 500mg Tab Susp; Enbrel 50mg/ml PFS; Prevacid FasTab 30mg Tab DR; Saizen 8.8mg vial for Inj; Aclasta 5mg/100ml IV Sol;
Revised Criteria: Xeloda 150mg, 500mg Tab; Zanaflex and generics 4mg Tab;
Reviewed and not Listed: Vantas 50mg Subdermal implant; Tysabri 300mg/15ml Vial for IV infusion, Denavir 1% top crm; Sutent (for metastatic renal cell carcinoma) 12.5mg, 25mg, 50mg caps; Diovan 40mg Tabs
Posted September 5, 2007
Alberta
Additions to AHWDBL, effective Sept 1, 2007
Highlights
New Interchangeable products: Novo-Olanzapine 2.5mg, 5mg, 7.5mg, 10mg, 15mg Orl Tab
Posted September 5, 2007
Nova Scotia
NS Pharmacare Bulletin Vol#07-08, August 2007
Highlights
New Products: Effective September 01, 2007: Altace HCT 2.5/12.5mg, 5/12.5mg, 10/12.5mg, 5/25mg, 10/25mg Tab; Azilect 0.5mg, 1mg Tab; Denavir 1% Crm; Exjade 125mg, 250mg, 500mg Tab for Susp; Orencia 250mg/vial Inj; Somatuline Autogel 60mg/0.3ml, 90mg/0.3ml, 120mg/0.3ml Syringe Inj; Tramacet Tab; Vantas 50mg/vial Inj.
New Ostomy Care Products: 50 New products, see list for details.
Interchangeable Products Added: pms-ASA EC 650mg EC Tab; ratio-Bupropion SR 100mg, 150mg SR Tab; Apo-Famiclovir 125mg, 250mg, 500mg Tab; Novo-Fenofibrate-S 100mg, 160mg Tab; pms-Leflunomide 10mg, 20mg Tab; pms-Levetiracetam 250mg, 500mg, 750mg Tab; RAN-Pravastatin 10mg, 20mg, 40mg; Novo-Ramipril 1.25mg, 2.5mg, 5mg, 10mg Cap; Sandoz Risperidone 0.25mg Tab; Ratio-Tamsulosin 0.4mg Cap; Sandoz Tamsulosin 0.4mg Cap.
New Categories: Apo-Cefprozil 125mg/5ml, 250mg/5ml O/L, 250mg, 500mg Tab; Cefzil 125mg/5ml, 250mg/5ml O/L, 250mg, 500mg Tab; RAN-Cefprozil 250mg/5ml O/L, 250mg, 500mg Tab; Rocephin 1g/vial, 2g/vial Inj; Ceftriaxone 1g/vial, 2g/vial Inj; Apo-Fluticasone 50mcg/dose Nas Spray; Flonase 50mcg/dose Nas Spray; Ratio-Fluticasone 50mcg/dose Nas Spray. Discontinued: Permax 0.05mg, 0.25mg, 1mg Tab.
Posted August 30, 2007
British Columbia
BC Pharmacare Bulletin, Edition 07-006 Aug 30, 2007
Highlights
Tamiflu remains covered for plan B for 2007-2008 season
Posted August 30, 2007
Ontario
ODB Edition 40, Update 4, Sept 4, 2007 revised
Highlights
2 changes to OFI products. Price correction for Apo-Pramipexole; Removal of ratio-Fluticasone from the OFI List
Posted August 27, 2007
Ontario
ODB Edition 40, Update 4 Sept 4, 2007
Highlights
New Single Source Drugs: Kaletra 200mg/50mg Tab; Truvada 200mg/300mg Tab;
New Multisource Drugs: Apo-Cefprozil 125mg/5ml, 150mg/5l Orl Susp; Apo-Clarithromycin 250mg Tab; Apo-Ranitidine 15mg/ml Orl Sol; Ceftriaxone Sodium for Injection 0.25g/vial; 1g/vial, 2g/vial; Gen-Clarithromycin 250mg Tab; Gen-Gliclazide 80mg Tab; Gen-Ondansetron 4mg, 8mg Tab; Novo-Desmopressin 0.1mg, 0.2mg Tab; PMS-Hydrochlorothiazide 25mg, 50mg Tab; Ran-Cefprozil 250mg/5ml Orl susp; Ran-Pravastatin 10mg, 20mg, 40mg Tab; Ratio-Clarithromycin 250mg Tab; Sandoz-Tamsulosin 0.4mg Cap.
Delisted: Tapazole 5mg Tab; 16 price changes - see update for details.
Not-A-Benefit drugs removed from Listing: Novo-Levofloxacin 250mg, 500mg Tab; 34 Off
Formulary Interchangeable Products - See update for details
Posted August 20, 2007
Newfoundland
NLPDP Bulletin No 44, Aug 13, 2007
Highlights
New Open benefits: Altace HCT 2.5/12.5mg, 5/12.5mg,10/12.5mg, 5/25mg, 10/25mg Tab; Altace 15mg Cap; DDAVP melts 60ug, 120ug Tab; pms-dexamethasone 2mg Tab; Linessa 21s and 28s.
Special Authorization Additions: Kaletra 200/50ug Tab; Orencia 250mg Vial; Humira 40mg Kit; Sutent 12.5mg, 25mg, 50mg Cap; Rituxan 10mg/ml Vial; Prezista 300mg Tab; Duragesic 12.5mg Patch; Revatio 20mg Tab; Biphentin 10mg, 15mg, 20mg, 30mg, 40mg, 50mg, 60mg Cap; Rebif Initiation Pack; Avalide 300/25mg Tab; Pariet 20mg Tab.
Posted August 13, 2007
Alberta
Additions effective August 01, 2007
Highlights
Addtion: Celebrex 100mg, 200mg Orl Cap.
Posted August 3, 2007
Nova Scotia
NS Pharmacare Bulletin July 2007 - Volume #07-07
Highlights
Changes in Publicly Funded Drug Program Pricing Procedure effective August 15, 2007; New Special MAC Category: Desmopressin 60 mcg, 120mcg Tab;
Temporary Reimbursement at AAC: Mirtazapine 15mg, 30mg, 45mg Tab;
Removed From Reimbursement List: 30 products;
Delisted: 11 products;
Discontinued: 118 products.
Posted August 3, 2007
Prince Edward Island
MAC List July 23, 2007 and MAC update bulletin
Highlights
New Interchangeable MAC List: Effective July 23, 2007: Zyprexa 2.5mg, 5mg, 7.5mg, 10mg, 15mg Tab; Novo-Olanzapine 2.5mg, 5mg, 7.5mg, 10mg, 15mg Tab; Peromax 0.05mg, 0.25mg, 1mg Tab; Apo-Pergolide 0.05mg, 0.25mg, 1mg Tab;
Products Added To The Interchangeable MAC List: Novo-Fenofibrates-s 100mg, 160mg Tab; Pms-Asa EC 325mg EC Tab; Pms-Levetiracetam 250mg, 500mg, 750mg Tab; Ratio-Fluticasone 50mcg/dose Nasal Spray;
Changes To MAC Prices: Entrophen 325mg Tab Ent; Novasen 325mg Tab Ent; Asadol 325mg Tab Ent; Pms-Asa-EC 325mg Tab Ent; Clozaril 25mg, 100mg Tab; Gen-Clozapine 25mg, 100mg Tab; Apo-Clozapine 25mg, 100mg Tab; Lyderm 0.05% Top Crm, 0.05% Top Gel; Lidex 0.05% Top Crm; Lyderm 0.05% Top Gel;
Deleted Interchangeable MAC Categories: Levaquin 250mg, 500mg Tab; Novo-Levofloxacin 250mg, 500mg Tab;
Discontinued Products: Pms-Asa EC 325mg EC Tab; Parlodel 2.5mg Tab;
Status Change: Zyprexa Zydis Orl Dis Tab; Criteria have been removed from Flomax and all interchangeable Tamsulosin 0.4mg sustained release cap.
Posted August 2, 2007
Québec
Liste de Medicaments, Capsule Aug 2, 20007
Highlights
Exception Drug Addtion: Sprycel 20mg, 50mg, 70mg Tabs; Discontinued by request of manufacturer: Diphenist 50mg/ml inj sol; Morphine (Mayne) 2mg/ml inj sol.
Posted August 2, 2007
British Columbia
BC Pharmacare Newsletter Edition 07-005, Aug 2, 2007
Highlights
New Drugs Categorized to LCA and/or RDP: Novo-Ramipril 1.25mg, 2.5mg, 5mg, 10mg Tab; Pms-Leflunomide 10mg, 20mg Tab; Pms-Levetiracetam 250mg, 500mg, 750mg Tab; Ran-Pravastan 10mg, 20mg, 40mg Tab;
Benefits: Alvesco 100mcg, 200mcg Metered Dose Inhaler;
New Brand Drugs Categorized To LCA: Lipidil EZ 48mg, 145mg Tab, DDAVP Melt 60mcg, 120mcg Orl Disintegrating Tab.
Limited Coverage Program: Avandamet 1mg/500mg, 2mg/500mg, 4mg/500mg, 2mg/1000mg, 4mg/1000mg Tab; Diovan 40mg, 320mg Tab; Lantus 100IU/ml Vial; Lantus 100IU/ml Cartridge; Spriva 18mcg Cap for Inhalation; Vfend 50mg, 200mg Tab; Vfend 200mg IV Infusion;
Non Benefits: Apo-Cefprozil 250mg, 500mg Tab; Apo-Flucitazone 50mcg Metered Dose Nasal Spray; Ran-Cefprozil 250mg, 500mg Tab, Ran-Cefprozil 250mg/5ml Orl Pwd For Susp; Ratio-Flucitasone 50mcg Metered Dose Nasal Spray; Aclasta 5mg/100ml IV Sol for Infusion; Azilect 0.5mg, 1.0mg Tab; Denavir 1% Top Crm.
Posted July 25, 2007
Nova Scotia
NS Formulary & Pharmacare Bulletin July 2007, Reimbursement List Aug 2007
Highlights
Replacement of MAC list with Reimbursement List; Discontinued: 119 products - see list for details
Posted July 20, 2007
Prince Edward Island
PEI Formulary Update Issue 07-03, July 10, 2007
Highlights
Coverage Of: Zyprexa Zydis Orally Disintegrated Tablets;
Coverage Of: Clorazil Effective July 23, 2007;
Status Change: Flomax 0.4mg Sustained Release Capsules;
Change In Criteria: Capecitabine Effective July 1, 2007.
Posted July 18, 2007
New Brunswick
Benefit Changes to NBPDP Bulletin #689, July 18, 2007
Highlights
Special Authorization Additions: Prezista 300mg Tab for Plan U (HIV-infected persons); Rituxan 100mg/vial, 500mg/vial for IV injection; Revatio 20mg Tab; Sutent 12.5mg, 25mg, 50mg Cap.
Drugs Reviewed And Not Listed: Azilect 0.5mg, 1mg Tab; Nexavar 200mg Tab.
Posted July 16, 2007
New Brunswick
Benefit Changes to NBPDP Bulletin #686, July 11, 2007
Highlights
Regular Benefit Additions: Eligard 45mg Sus SC; Risperdal 1mg/ml Orl Liq; pms-Risperidone 1mg/ml Orl Liq; Apo-Risperidone 1mg/ml Orl Liq;
No Longer Requires Special Authorization: Risperdal 0.25mg, 0.5mg, 1mg, 2mg, 3mg, 4mg Orl Tab; pms-Risperidone 0.25mg, 0.5mg, 1mg, 2mg, 3mg, 4mg Orl Tab; ratio- Risperidone 0.25mg, 0.5mg, 1mg, 2mg, 3mg, 4mg Orl Tab; Sandoz- Risperidone 0.25mg, 0.5mg, 1mg, 2mg, 3mg, 4mg Orl Tab; Ran-Risperidone 0.25mg, 0.5mg, 1mg, 2mg, 3mg, 4mg Orl Tab; Apo-Risperidone 0.25mg, 0.5mg, 1mg, 2mg, 3mg, 4mg Orl Tab; Gen-Risperidone 0.25mg, 0.5mg, 1mg, 2mg, 3mg, 4mg Orl Tab; Co-Risperidone 0.25mg, 0.5mg, 1mg, 2mg, 3mg, 4mg Orl Tab; Co-Risperidone 0.25mg, 0.5mg, 1mg, 2mg, 3mg, 4mg Orl Tab; Novo-Risperidone 0.25mg, 0.5mg, 1mg, 2mg, 3mg, 4mg Orl Tab; Valtex 500mg orl Tab.
Special Authorization Additions: Oxicontin 5mg controled release Tab; Avandamet 1mg/500mg, 2mg/500mg, 4mg/500mg, 2mg/1000mg, 4mg/1000mg Tab; Risperdal M-Tab 3mg, 4mg Orally disintegrating Tablets.
Change in Benefits Status: Risperdal M-Tab 0.5mg, 1mg, 2mg Orally disintegrating Tablets.
Drugs Reviewed And Not Listed: Botox 100IU/vial, Atacand 4mg Tab;Niaspan 500mg, 750mg, 1000mg ER Tab; PravASA 10mg, 20mg, 40mg Tab packed with ASA 81mg Delayed release Tab; Ketek 400mg Tab.
Posted July 11, 2007
Nova Scotia
NS Pharmacare June 2007 Vol #07-06
Highlights
New Products: Effective July 1, 2007 Avalide 300/25mg Tab; DDAVP MELT 60mcg, 120mcg Tab; Keletra 250/50mg tab; Pariet 20mg EC Tab, pms-Dexamethasone 2mg Tab;
New Diabetic & Ostomy Products: Effective July 1, 2007 Abbot Thin 28g Lancet 100/200 box, Ascensia Breeze 2 Test Strip Disc 50/100 box; Ascensia Contour Test Strip 50/100 box; BD Ultra Fine Lancets 100 box; Assura Easiclose Drainable Pouch.
Delisted Products: Effective August 1, 2007 Apo-Zopiclone 7.5mg Tab, Co Zopiclone 7.5mg Tab, Gen-Zopiclone 7.5 mg Tab, Imovane 7.5 mg Tab, Novo-Zopiclone 7.5 mg, Nu-Zopiclone 7.5 mg Tab, pms-Zopiclone 75.mg Tab, RAN-Zopiclone 7.5 mg Tab, ratio-Zopiclone 7.5mg Tab, Rhovane 7.5mg Tab, Sandoz Zopiclone 7.5mg Tab.
Posted July 13, 2007
Ontario
ODB Edition 40, Update 3 A effective July 12, 2007
Highlights
16 Price Changes - See list for details.
Posted July 11, 2007
Newfoundland
Full Interchangeable Formulary Release June 28, 2007
Highlights
Full Interchangeable Formulary Release.
Posted July 11, 2007
Saskatchewan
Saskatchewan Bulletin #111 July 2007
Highlights
New Exception Drugs: Aranesp 200mcg/ml p.f. syringe(0.65ml); Exjade 125mg, 250mg, 500mg Tab for oral suspesion; Prevacid FasTab 15mg orl dis Tab; Remodulin 1mg, 2mg, 5mg, 10mg inj sol (bill/ml); Supplies-per diem Remodulin Supplies; Risperdal Consta 25mg/vial, 37.5mg/vial, 50mg/vial pwd for inj.
New Full Benefits: Alvesco 100mcg, 200mcg m.d.i.;
New Interchargable Listings Effective June 01/07: pms-ASA EC 650mg EC tab; ratio-Fluticasone 50 NS 50mcg/act. metered dose nasal spray; pms-levetiracetam 250mg, 500mg, 750mg Tablet; Ran-Pravastin 10mg, 20mg, 40mg Tablet; Sandoz Tamsulosin 0.4mg Sustained Release Capsule; Sidekick srip.
Posted July 11, 2007
Alberta
AHWDBL Quarterly Update, AEIIDBS Quarterly Update & DBL report, Full DBL list July 2007
Highlights
Highlights of new products added: Diovan 320mg tab; aapo-desmopressin 0.1mg, 0.2mg tab; Apo-ondansetron 4mg, 8mg tab; Apo-perindropril 8mg tab.
Highlights of Special Authorization Criteria Changes: Pegasys RBV; Pegetron; Plavix.
Highlights of Special Authorization Products Added: Sandoz alendronate 10mg, 70mg tab.
Highlights of products not added: Humalog mix50 50%/50% injection cartridge.
Changes in Benefit Status: Ventolin nebules P.F.; Eumovate 0.05% top crm.
Added Product: Apo-cilazapril 2.5mg, 5mg tab; Apo-desmopressin 0.1mg, 2mg tab; Apo-medroxy 10mg tab; Apo-ondansetron 4mg, 8mg tab; Apo-perindopril 8mg tab; Co cilazapril 2.5mg, 5mg tab; Co pravastatin 10mg, 20mg, 40mg tab; Diovan 320mg tab; Pms-digoxin 0.125mg, 0,25mg tab; Pms-pramipexole 0.25mg, 1mg, 1.5mg tab; Ran-citalo 20mg, 40mg tab; Ratio-bupropion sr 100mg, 150mg tab; Sandoz fenofibrate s 100mg 160mg tab
Change in Status from Special Authorization to Unrestricted Product(s): Apo-salvent sterules 2mg/ml inh sol; Gen-salbutamol sterinebs p.f. 2mg inh sol; Nu-salbutamol 2mg/ml inh sol, Pms-salbutamol 2mg/ml inh sol; Ratio-salbutamol sulfate 2mg/ml inh sol; Ventolin nebules p.f. 5mg/2.5ml inh sol.
Discontinued Listing(s): Apo-levobunolol 0.25% oph sol combivent inh aer; delestrogen 10mg/ml inj; Diflucan 50mg, 100mg tab; Novo-misoprostol 200mcg tab; Pms-nylidrin 6mg tab; Provera pak 10mg tab; Ratio-mpa 2.5mg, 5mg, 10mg tab; Sab-naproxen 500mg rectal supp; Surgam SR 300mg cap; Tiaprofenic acid Trasicor 80mg tab; Ventodisk inh app; Zyloprim 200mg tab.
Discontinued Special Authorization Listing: STIEVA-A 0.01% TOP GEL.
Drug Additions: Ratio, Sandoz-bupropion SR 100mg, 150mg tab; Apo, Co, Gen, Novo, Pms, cilazapril 2.5mg, 5mg; Apo, Co, Gen, Novo, Pms, Ran, Ratio, Sandoz-citalopram 20mg, 40mg tab. Ran-citalo 20mg, 40mg; Apo-desmopressin 0.1mg, 0.2mg tab; Apo, Pms-digoxin 0.125mg, 0.25mg tab; Apo-feno-super 100mg tab, 160mg cap; Sandoz fenofibrate s 100mg tab, 160mg cap; Fenomax cap; Apo, Gen-medroxy; Novo-medrone; Pms-medroxyprogesterone 10mg tab; Novo, Sandoz, Ratio –ondansetron 4mg, 8mg tab; Apo-perindopril 8mg tab; Novo-pramipexole 0.25mg, 1mg, 1.5mg tab; Apo, Co, Gen, Novo, Nu, Pms, Ratio, Sandoz-pravastatin 10mg, 20mg, 40mg tab; Apo-salvent sterules 2 mg/ml; Gen, Nu, Pms, Ratio-salbutamol p.f. 2mg/ml.
Posted July 4, 2007
Québec
Quebec modification no1 a la Liste de medicaments, effective June 27, 2007
Highlights
40 Products readded to Liste de Medicaments (see list for details)
Posted July 3, 2007
Prince Edward Island
PEI May 28, 2007 Bulletin
Highlights
EDS additions: Cefzil 250mg, 500mgTab, 25mg/ml, 50mg/ml O/Susp; Apo-Cefprozil 250mg, 500mg Tab; 25mg/ml, 50mg/ml O/Susp; Ran-Cefprozil 50mg/ml. Truvada 300mg & 200mg Tab; Cipro XL 1000mg Tab ER; Twinject 0.15mg/dose, 0.3mg/dose auto-injector; Peridex 0.12% Oral Rinse; Pericholor 0.12% Oral Rinse; Avandamet 1mg & 500mg, 2mg &500mg, 4mg & 500mg, 2mg & 1000mg Tab; DDAVP 0.1mg Tab; 0.2mg Tab; Apo-Desmopresin 0.1mg, 0.2mg Tab; Uromax 10mg, 15mg Tab CR; Trosec 20mg Tab; Humira 40mg/0.8ml Pre-filled syringe, Flolan 0.5mg, 1.5mg PWS inj; Tracleer 62.5mg, 125mg Tab; Flomax 0.4mg Cap SR; Novo-Tamsulosin 0.4mg Cap SR; Ratio-Tamsulosin 0.4mg Cap SR; Accolate 20mg Tab; Aclasta 5mg/100ml Inj;
Full Benefit Additions: Trelstar 3.75mg, 11.25mg IM inj; Lipidil Supra 100mg, 160mg Tab; Apo-Feno-Super 100mg, 160mg Tab; Sandoz Fenofibrate S 100mg, 160mg Tab; Lescol XL 80mg Tab Sust. Release; Advicor 20mg &500mg, 20mg & 1000mg Tab ER; Cardura 1mg, 2mg, 4mg Tab; Gen-Doxazosin 1mg, 2mg, 4mg Tab; Apo-Doxazosin 1mg, 2mg, 4mg Tab; Novo-Doxazosin 1mg, 2mg, 4mg Tab; PMS-Doxazosin 1mg, 2mg, 4mg Tab; Coversyl 8mg Tab; Apo-Perindopril 8mg Tab; Voltaren SR 100mg Tab Sust Release;Novo-Difenac SR, Apo-Difenac SR; Nu-Diclofenac SR; PMS-Diclofenoac SR; Sandoz Diclofenac SR 100mg Tab Sust Release; Naprosyn-E 250mg, 375mg, 500mg, 750mg Tab EC; Novo-Naproxen EC 250mg, 375mg, 500mg Tab EC; Apo-Naproxen EC 250mg, 375mg, 500mg, 750mg Tab EC; Gen-Naproxen EC 375mg, 500mg Tab EC; Nasonex 100mg/dose Nas spray; Nasacort AQ 55UG/Dose Nas Spray; Duotrav; Alvesco 100UG/Dose, 200UG/Dose Inh Aerosol; Nuvaring; Premplus 0.625 & 2.5mg, 0.625 & 5mg Tab; Vagifem 25UG Vag Tab; Avandamet 1mg & 500mg, 2mg & 500mg, 4mg & 500mg, 2mg & 1000mg, 4mg & 1000mg Tab
Posted June 27, 2007
New Brunswick
Full Formulary Edition, Interchangeable Formulary June 2007
Highlights
Full formulary release.
Posted June 22, 2007
Québec
Quebec capsule, liste des hausses de prix applicable, Liste de Medicaments June 22, 2007
Highlights
Additons: Alvesco 100mcg/dose, 200mcg/dose; Apo-Digoxin 0.0625mg, 0.125mg, 0.25mg Tab; Fosamax 70mg/75ml oral sol;
Exception Addtions: Biphentin LA 10mg, 15mg, 20mg, 30mg, 40mg, 50mg, 60mg Cap; Levemir 100u/3ml Inj SC Sol; Orencia 250mg IV; Tygacil 50mg IV; Hepsera 10mg Tab; Humira 40mg SC Inj Sol; Sutent 12.5mg, 25mg, 50mg Cap
Change of criteria: Pegasys RBV; Pegetron, Pegetron Redipen, Zyvoxam.
Declined - Therapeutic value: Exjade.
Declined - Due to Price: Enbrel, Factive, Fosrenol,Nexavar, Raptiva.
Declined - Due to therapeutic value and price: Tysabri.
Price changes - see marque de commerce document.
Posted June 19, 2007
Newfoundland
Newfoundland Bulletin Spring 2007
Highlights
New open benefits: Trelstar 3.75mg, 11.25mg; Advicor 100/20, 500/20; Dutotrav; PMS-Citalopram 10mg; Alvesco 100mcg, 200mcg Inh; Hydro Val 0.2% cream & oint.
Special Authorization additons: Norprolac; Trosec; Risperdal M-Tabs; Vfend.
New criteria: Aranesp, Humira.
Reviewed and not considered for coverage: Amevive; Fosavance, Enablex; Novomix 30; Cipralex; Vesicare; Xolair; Levemir; Hepsera; Somavert; Lantus; Altace plue Felopidine
Posted June 19, 2007
New Brunswick
NB Bulletin #685, June 11, 2007
Highlights
Benefit Additions: Ceftriaxone 1gm, 2gm Inj Pws; Apo-Cilazapril 1mg, 2.5mg, 5mg Tab; Co-Cilazapril 2.5mg, 5mg Tab; Apo-Famciclovir 125mg, 250mg, 500mg Tab; Novo-Fenofibrate S 100mg, 160mg Tab; pms-Fluconazole 150mg Cap; Apo-Fluticasone 50mcg Orl Aem; pms-Leflunomide 10mg, 20mg Tab; Ondansetron(Preservative Free) 2mg/ml Inj; Ondansetron(With Preservative) 2mg/ml Inj; Supeudol 10mg, 20mg Tab; Apo-Perindopril 8MG Tab; Apo-Pramipexole 0.25mg, 0.5mg, 1mg, 1.5mg Tab; Novo-Ramipril 1.25mg, 2.5mg, 5mg, 10mg Caps; Sandoz-Risperidone 0.25mg Tab; Co-Sertraline 25mg, 50mg, 100mg Cap; ratio-Tamsulosin 0.4mg SRC Cap; Sandoz-Tamsulosin 0.4mg SRC Caps; Ran-Cefprozil 250mg/ml Pwd; Apo-Cefprozil 250mg, 500mg Tab; Ran-Cefprozil 250mg, 500mg Tab; GPI-Lactulose 667mg/ml Orl Syr.
Posted June 12, 2007
Alberta
Additions effective June 6, 2007
Highlights
Addition: Ratio-Omeprazole 20mg SRC
Posted June 6, 2007
British Columbia
BC Pharmacare Bulletin #07-004 effective June 6, 2007
Highlights
LCA/RDP Booklet Changes: See bulletin for details.Benefits: Alphagan P 0.15% oph sol; Flomax CR 0.4mg Tab CR;
Palliative Care only Benefits: Apo-Famciclovir 125mg, 250mg tab;
Blood Glucose Test Strips: Ascensia Contour, Ascensia Breeze 2;
Limited Coverage: Cosopt Preservative-Free oph sol; Enbrel 25mg vial, 50mg PFS; Trusopt preservative-free 2% oph sol;
Non-Benefits: Cipralex 10mg, 20mg tab; Vesicare 5mg, 10mg Tab;
Removed from benefit list at request of manufacturer as of July 9, 2007: Novasen 325mg tab; Gabapentin 300mg cap;
Other Non-Benefit Drugs: Prezista, Sutent, Vantas, Nexavar
Posted June 1, 2007
Ontario
ODB Edition 40, Update 2 effective June 6, 2007
Highlights
New Single Source Drugs: Altace HCT 2.5mg & 12.5mg Tab, 5mg & 12.5mg Tab, 10mg & 12.5mg Tab, 5mg & 25mg Tab, 10mg & 25mg Tab; alvesco 100mcg/Act 120 Dose pk, 200mcg/act 120 Dose pk; DDAVP Melt 60mcg ODT, 120mcg ODT; Yasmin 21, Yasmin 28.
Multi-Source Drugs: Apo-Cefprozil 250mg, 500mg Tab; Apo-Gliclazide 80mg Tab; Novo-Fenofibrate-S 160mg Tab; Novo-Gliclazide 80mg Tab; Novo-Ramipril 1.25mg, 2.5mg, 5mg, 10mg cap; PMS-Leflunomide 10mg, 20mg Tab; Ran-Cefprozil 250mg, 500mg Tab; Ratio-tamsulosin 0.4mg Cap.
Manufacturer requested discontinued products: Gabapentin 300mg cap (Genpharm); Norpace 100mg, 150mg cap; Novo-Misoprostol 200mcg Tab; Ratio-Ipratropium 0.03% Nas Spray; Ratio-Nystatin 10000U Vag Tab; Not a Benefit (removed from Listing) - Bleph-10 10% Oph Sol; Sulamyd 10% Oph Sol;
Status change from LU to Full Benefit: Actonel 5mg, 30mg, 35mg Tab;
Discontinued Drugs (removed from payment & listing) PMS-Dipivefrin 0.1% Oph Sol Reinstated Drug: Myochrysine 25mg/ml inj sol
Posted May 29, 2007
New Brunswick
New Brunswick Bulletin #682, effective May 24, 2007
Highlights
Regular Benefit Additions: Alvesco 100mg, 200mg Inh Aer; Imdur, Apo-ISMN 60mg Tab;
No longer requires special authorization: Heptovir 100mg Tab; Novo-Tamsulosin 0.4mg Cap;
Special Authorization Addtions: Flolan 0.5mg, 1.5mg vials for inj; NuvaRing 11.4mg/2.6mg vag ring;
Revised Criteria: Humira 40mg/0.8ml inj;
Reviewed and not Listed: Hepsera 10mg tab; Cipralex 10mg, 20mg Tab; Vesicare 5mg, 10mg Tab.
Posted May 29, 2007
British Columbia
BC Pharmacare Bulletin #07-003 effective May 25, 2007
Highlights
Changes to dispensing of Plan B 0.75mg
Posted May 28, 2007
Alberta
Alberta Additions effective May 1, 2007
Highlights
Addition: Novo-Tamsulosin 0.4mg sust rel cap
Posted May 24, 2007
Québec
Modification #1- May 18, 2007
Highlights
New DIN: Gen-Combo Sterinebs 0.2mg - 1mg/ml (2.5ml) new DIN 2272695
Posted May 16, 2007
Nova Scotia
NS Pharmacare Bulletin, Vol. 07-05, May 2007
Highlights
New Exception Status Products: Biphentin 10mg, 15mg, 20mg, 30mg, 40mg, 50mg, 60mg, 80mg Cap; Revatio 20mg Tab; Rituxan 10/ml Inj, Truvada Tab; Vesicare 5mg, 10mg Tab;
Not Insured: Cipralex 10mg, 20mg Tab; Nexavar 200mg Tab; Prezista 300mg Tab;
New Ostomy Products (see list),
New WoundCare Products (see list)
Delisted Diabetic Products (see list)
Posted May 8, 2007
Alberta
Additions AEIIDBS Effective April 1, 2007
Highlights
Additions: Canesten External Cream Refill, Clotrimaderm, Canesten 6 1% Vag Cr; Clotrimaderm, Canesten 3 2% Vag Cr; Canesten 1 10% Vag Cr; Canesten 3 Comfortab Combi-Pak 1%, Canesten 1 Comfortab Combi-Pak 1%, Canesten 1 Cream Combi-Pak 10%; Micozole, Monistat 7 2% Vag Cr; Monistat 3 4% Vag Cr; Miconazole 3 day ovule, Monistat 3 400mg Vag Ovule; Monistat 1 1200 Vag Ovule; Monistat 7 Dual-Pak 2%; Monistat 3 Dual-Pak 2%; Monistat-1 Combination Pak
Posted May 8, 2007
New Brunswick
NB Bulletin #680, Effective Apr 30, 2007
Highlights
Regular Benefit Additions: Tri-Cyclen Lo (21 & 28); DuoTrav.
No longer Requires Special Authority: Lumigan 0.03%; Xalatan 50mcg/ml Oph Sol; Xalacom 50mcg/5mg/ml Oph Sol; Travatan 0.004% Oph Sol;
Special Authorization Additions: Flomax CR 0.4mg Caps; Truvada 300mg/200mg Tab; Trosec 20mg Tab.
Special Authorization - Revised Criteria: Proscar 5mg Tab; Vfend 50mg, 200mg Tabs.
Drugs Reviewed and Not Listed: Amevive; Fosavance; Enablex; Lipidil EZ; Lantus; Venofer
Posted May 8, 2007
Québec
Correction no.2, effective April 18, 2007
Highlights
See list for details.
Posted May 1, 2007
Ontario
Ontario Update #1, Edition 40, effective May 4, 2007
Highlights
New Single Source Drugs: Prezista 300mg Tab; New Multi-Source Drugs: Ceftriaxone 1g/vial, 2g/vial Inj Pd; Ran-Citalo 20mg, 40mg Tab; Sandoz Risperidone 0.25mg Tab.
Manufacturer Requested Discontinued Drugs: Novo-Diflunisal 500mg Tab; Novo-Naprox 750mg SR Tab; Sandoz Risperidone 0.25mg Tab; Zyloprim 200mg Tab.
Delisted Drugs: Kidrolase Inj Pd.
18 Price changes: See update for details.
Not-A-Benefit Drugs: Diocarpine 1%, 2% Oph Sol; Ditropan 5mg Tab; Flomax 0.4mg Cap; Floxin 300mg, 400mg Cap; Myochrysine 25mg/ml Inj Sol;
Discontinued Drugs - Removed From Payment & Listing: Apo-Cimetidine 60mg/ml O/L; Apo-Cyclosporine 100mg/ml O/L; Apo-Doxepin 150mg Cap; Apo-Ipravent 125mcg/ml Oph Sol; Apo-Ipravent Sterule 250mcg/ml Oph Sol; Apo-Tobramycin 0.3% Oph Sol; Balminil DM 3mg/ml O/L; Betagan 0.25% Oph Sol; Cytovene 500mg/vial Pd Inj; Ocufen 0.03% Oph Sol; PMS-Potassium Gluconate 1.33Eq/ml O/L; Propine 0.1% Oph Sol; Ratio-Methylphenidate 10mg Tab; Reminyl 4mg, 8mg, 12mg Tab; Sintrom 1mg, 4mg Tab;
Not-A-Benefit Drugs Removed From Listing: Kaon 1.33mg/ml O/L; Quinidine 200mg Tab; Tagamet 60mg/ml O/L;
Posted April 19, 2007
British Columbia
BC Pharmacare Bulletin April 18, 2007
Highlights
Effective April 23, 2007. Implementation Of Methadone Prescribing Status On Pharmanet.
Posted April 19, 2007
Québec
Full Formulary April 2007
Highlights
Full formulary release.
Posted April 11, 2007
NIHB
NIHB Winter 2006-2007 Drug Benefit list and updates
Highlights
Full formulary release.
Posted April 3, 2007
Newfoundland
NLPDP Interchangeable Formulary March 27, 2007
Highlights
Interchangeable formulary release.
Posted April 3, 2007
Alberta
Alberta DBL report,
Full Formulary,
AEIIDBS,
Summary of Changes April 1, 2007
Highlights
Highlights of products added: Apo-Digoxin 0.0625mg, 0.125mg, 0.25mg Tab; Novo-Venlafaxine XR 37.5mg, 75mg, 150mg ER Tab; Sandoz Bupropion SR 100mg, 150mg SR Tab.
Changes In Benefit Status Of Vaginal Anti-infective Products, Parasympathhomimetics Papaverine and Interon: Effective April 01, 2007.
Addition Of Special Authorization Products: Cosopt 2%/0.5% Oph Sol; Trusopt 2% Oph Sol; Humira 40mg/0.8ml Inj; Sandoz Cyclosporine 25mg, 20mg Cap.
Products Not Added: Betaseron 0.3mg Inj.
Posted April 2, 2007
Nova Scotia
NS Pharmacare Bulletin Vol7-04, March 2007
Highlights
New ostomy Products Effective April 01, 2007: Assura Easiclose Drainable Pouch #14498; Assura Std Wear Drainable Easiclose Pouch #14491; Easiflex Drainable Pouch w Easyclose #14525; Easiflex Drainable Pouch w Easyclose #14529.
Interchargable Products Added To Nova Scotia Formulary: Alendronate 5mg, 10mg, 70mg Tab; Cilazapril 1mg, 2.5mg, 5mg Tab; Fenobibrate 100mg, 160mg, Tab; Fentanyl 25mcg/hr, 50mcg/hr, 75mcg/hr, 100mcg/hr Patch; Hydrochlorothiazide 25mg, 50mg Tab; Lactulose 667mg/ml O/L; Ondansetron 4mg, 8mg Tab; Pravastin 10mg, 20mg, 40mg Tab; Sertraline 25mg, 50mg, 100mg Tab; Sumatriptan 25mg, 50mg, 100mg Tab; Ticlopidine 250mg Tab; Trazodone 50mg, 100mg, 150mg Tab.
New categories: Apo-Desmopressin 0.1mg, 0.2mg, Tab; DDAVP 0.1mg, 0.2mg Tab; Apo-Digoxin 0.0625mg, 0.125mg, 0.25mg Tab; Lanoxin 0.0625mg, 0.125mg, 0.25mg Tab; pms-Digoxin 0.125mg, 0.25mg Tab; Accutane 10mg, 40mg Cap; Clarus 10mg, 40mg Cap;Apo-Perindopril 8mg Tab; Coversil 8mg Tab; Apo-Pramipexole 0.25mg, 0.5mg, 1mg, 1.5.g Tab; Mirapex 0.25mg, 0.5mg, 1mg, 1.5.g Tab; Novo-Pramipexole 0.25mg, 0.5mg, 1mg, 1.5.g Tab; pms-Pramipexole 0.25mg, 0.5mg, 1mg, 1.5.g Tab. Altace 1.25mg, 2.5mg 5mg, 10mg Cap; Apo-Ramipril 1.25mg, 2.5mg 5mg, 10mg Cap; ratio-Ramipril 1.25mg, 2.5mg 5mg, 10mg Cap. Flomax 0.4mg Cap; Novo-Tamsulosin 0.4mg Tab. pms-Ursodiol C 250mf, 500mg Tab; Urso 250mg, 500mg Tab.
Posted April 2, 2007
New Brunswick
NBPDP Formulary Mar 2007
Highlights
Full formulary release.
Posted April 2, 2007
Saskatchewan
Sask Bulletin #110, April 2007
Highlights
New Full Formulary Listings: Linessa 21, 28 Tab; Heparin 10.000U/ML Inj; iTest; True Track Smart System Test Strip; Sidekick Blood Glucose Test Strip.
New EDS Listings: Revatio 20mg Tab; Prezista 300mg Tab; Truvada 200mg/300mg Tab; Kaletra 200mg/50mg Tab.
Revised EDS Criteria: Cellcept, Agenerase, Telzir, Humira, Aptivus.
Under Review with the CDR: Denavir, Exjade, Myozyme, Orencia, Sutent, Tramacet, Tysabri, Vantas, Prexige, Azilect, Altace HCT, Sebivo, Baraclude.
Not Recommended for Coverage Via CDR: Hepsera 10mg Tab; Vesicare 5mg, 10mg Tab; Cipralex 5mg, 10mg Tab; Amevive 15mg/0.5ml; Enablex 7.5mg, 15mg Tab.
Other Products not Recommended by the Saskatchewan Review Committee: Trozec 20mg Tab; Fenomax 160mg Cap; Gen-Warfarin 6mg, 7.5mg Tab; Altace 15mg Cap; NuvaRing 12mcg/24h, 15mcg/24h VAG SDE; Niaspan 500mg, 750mg, 1000mg Tab ER, Remicade 100mg Inj & Enbrel 50mg Inj Coverage was not recommended for the treatment of ankylosing spondylitis as the clinical benefit does not justify the incremental cost.
Other Products Currently Under Review in Saskatchewan Include: Biphentin, Remodulin, Rituxan (for rhumatoid arthritis), Alvesco, Sandoz Cyclosporine
Posted March 28, 2007
Ontario
Update 16D, Edition #39 ODB Formulary/Comparative Drug Index effective Apr 2, 2007
Highlights
New Single Source Drugs: Coversyl Plus 4mg & 1.25mg Tab; Diamicron 80mg Tab; Diamicron MR 30mg SR Tab; Preterax 2mg & 0.625mg Tab
New Multi Source Drugs: Apo-Desmopressin 0.1mg, 0.2mg Tab; Apo-Famciclovir 500mg; Apo-Pramipexole 0.25mg, 1mg, 1.5mg Tab; Co Cilazapril 2.5mg, 5mg Tab; Co Pravastatin 10mg, 20mg, 40mg tab; Co Sertraline 25mg, 50mg, 100mg Caps; PMS-Urodiol C 250mg, 500mg Tab.
Manufacturer requested discontinuation: Apo-Levobunolol 0.25% oph sol, Apo-Sulfatrim 40mg & 8mg/ml O/L; Balminil DM 3mg/ml O/L; Stieva-A 0.01% gel;
Price changes to 67 products - see list for details.
Not a Benefit Drugs: Apo-Lisinopril 5mg, 10mg, 20mg Tabs; Nu-Triazide 25mg & 50mg Tab;
Limited Use Criteria Change: Femara 2.5mg tab;
Removed from Payment and Listing: Albert-Tiafen 200mg Tab; Alti-Bromazepam 6mg Tab; Asmavent 5mg/ml Inh Sol; Captril 100mg Tab; Codeine 30mg Tab; Deproic 50mg/ml O/L; Nemasol 500mg Tab; Quinidine 200mg Tab; Scabene 0.63% & 5.04% aer spray; Theophylline 5.3mg/ml O/L Trazorel 50mg, 100mg Tab
Posted March 21, 2007
British Columbia
BC Pharmacare Newsletter #07-001 Mar 21, 2007
Highlights
New Drugs Categorized to LCA and/or RDP: Apo-Levetiracetam 250mg, 500mg, 750mg Tab, Apo-Medroxy 10mg Tab, Apo-Mitrazapine 15mg, 30mg, 45mg Tab, Apo-Ondansetron 4mg, 8mg Tab, Fenomax (Fenofibrate) 160mg Cap, Gen-Warfarin 3mg Tab, Novo-Acyclovir 200mg, 400mg, 800mg Tab, Novo-Fenofibrate-S 160mg Tab, Novo-Sumatriptan DF 25mg, 50mg, 100mg Tab, PMS-Alendronate-FC 70mg Tab, PMS-Famciclovir 500mg Tab, Ratio-Bupropion SR 100mg, 150mg Tab, Sandoz Alendronate 10mg, 70mg Tab, Sandoz Fenofibrate S 100mg, 160mg Tab.
Limited Coverage Program: Duragesic 12 (Fentanyl) 12mcg/h Transdermal Patch, Risperdal Consta (Risperidone) 25mg, 37.5mg, 50mg powder/ injectable suspension.
Benefits: Gen-Warfarin 3mg Tab, pms-Citalopram 10mg Tab, Novo-Acyclovir 200mg, 400mg, 800mg Tab.
Benefits Palliative Care Drug Plan: pms- Famiciclovir 125mg, 250mg Tab, Duragesic 12 (Fentanyl)12mcg/h Transdermal patch, Sandoz Alendronate 5mg Tab, Novasen 650mg Tab.
Delisting Of PRODOC Products: At the request of the manufacturer, ProDoc Ltee, all ProDoc Products are being removed from the Pharmacare formulary.
Posted March 21, 2007
New Brunswick
NB Bulletin #677, Feb 23, 2007
Highlights
Benefit Additions: Sandoz-Alendronate 10mg, 70mg Tab; ratio-Bupropion SR 100mg, 150mg; Apo-Digoxin 0.0625mg, 0.123mg, 0.25mg Tab; pms-Digoxin 0.125mg, 0.25mg Tab; pms-Famciclovir 125mg, 250mg, 500mg Tab; Sandoz-Fenofibrate S 100mg, 160mg Tab; ratio-Fentanyl Transdermal 25mcg, 50mcg, 75mcg, 100mcg SR Trans Pad; Apo-Medroxy 10mg Tab; ratio-Omeprazole 20mg SRT; Apo-Ondansetron 4mg, 8mg Tab; pms-Pramipexole 0.25mg, 0.5mg, 1mg, 1.5mg; Novo-Pramipexole 0.25mg, 0.5mg, 1mg, 1.5mg; Apo-Ramipril 1.25mg, 2.5mg, 5mg, 10mg Cap; ratio-Ramipril 1.25mg, 2.5mg, 5mg, 10mg Cap; ratio-Trazodone 50mg, 100mg, 150mg Tab; pms-Ursodiol C 250mg, 500mg Tab;
Non-Listed Product subject to MAP: Sandoz-Alendronate 5mg Tab
Posted March 9, 2007
Ontario
Update 15A, Edition #39 ODB Formulary/Comparative Drug Index effective Mar 9, 2007
Highlights
New Multi-Source Drugs: Apo-Digoxin 0.0625mg, 0.125mg, 0.25mg Tabs; PMS-Digoxin 0.125mg, 0.25mg Tabs.
New Drug Benefit Price: Lumigan 0.03% Oph Sol
Posted March 7, 2007
Nova Scotia
Nova Scotia Maximum Allowable Cost Update. Vol #07-03
Highlights
A notification of changes to the MAC and special MAC pricing policy was provided in the Dec 2006 Pharmacists Bulletin. Discussions with the Pharmacy Association of NS regarding the scope and implementation of this policy began in Jan 2007 and are still ongoing. We anticipate competing thse discussions and geing able to provide you with details prior to April 1, 2007. The existing MAC list - effective Jan 15, 2007 will remain in effect until further notice.
Posted March 6, 2007
Ontario
Update 15, Edition #39 ODB Formulary/Comparative Drug Index effective Mar 9, 2007
Highlights
Additions - Single Source: Avalide 300mg & 25mg Tab;
Additons - Multi Source: Apo-Cilazapril 1mg, 2.5mg, 5mg Tab; Apo-Medroxy 10mg Tab; Apo-Ramipril 1.25mg, 2.5mg, 5mg, 10mg Cap Ratio-Ramipril 1.25mg, 2.5mg, 5mg, 10mg Cap, Gen-Alendronate 70mg Tab; PMS-Alendronate FC 70mg Tab; Sandoz Alendronate 10mg, 70mg Tab; PMS-Pramipexole 0.25mg Tab, 1.0mg Tab, 1.5mg Tab - for the indication of Parkinsons Disease; Novo-Pramipexole 0.25mg Tab, 1.0mg Tab, 1.5mg Tab - for the indication of Parkinsons Disease; Gen-Warfarin 3mg Tab;
Limited Use Multi Source additions: Apo-Ondansetron 4mg, 8mg Tab;
Discontinued by Manufacturer: Atrovent 250mcg/ml; Atrovent UDV 125mcg/ml, 250mcg/ml; Berotec Inh Pd & Inh Sol; PMS-Ticlopidine 250mg tab; Vaponefrin 2.25%
100 Price changes - see list for details;
Removed from payment and listing: Seroquel 150mg Tab;
Palliative Care: 47 products listed for Palliative Care - Facillitated Access program - see list for details.
Re-instated Drugs: Betaderm 0.05%, 0.1% Oint; Lin-Fosinopril 10mg, 20mg Tab.
Criteria change: Aromasin 25mg Tab
Posted March 3, 2007
Alberta
Alberta Additions effective Feb 1, 2007
Highlights
New Drug Products added to the AHWDBL: Sandoz Bupropion SR 100mg, 150mg Tab SR; Apo-Digoxin 0.0625mg, 0.125mg, 0.25mg Tab; Novo-Pramipexole 1mg, 1.5mg, 0.25mg Tab; Ratio-Ramipril 1.25mg, 2.5mg, 5mg, 10mg Cap; Novo-Venlafaxine XR 37.5mg, 75mg, 150mg Cap XR.
Posted March 3, 2007
New Brunswick
NB Bulletin #678, Feb 28, 2007
Highlights
Regular Benefit Additions: Diamicron 80mg, Gen-Gliclazide 80mg, Novo-gliclazide 80mg, Apo-gliclazide 80mg, Sandoz gliclazide 80mg Tab., Amaryl 1mg, Sandoz Glimepiride 1mg, 2mg, 4mg Tab., ratio-Glimepiride 1mg, 2mg, 4mg Tab., Novo-Glimepiride 1mg, 2mg, 4mg Tab, Co Glimepiride 1mg, 2mg, 4mg Tab., Trelstar SR 3.75mg, Trelstar LA 11.25mg,
Special Authorization addisions: Caduet 5/10mg, 5/20mg, 5/40mg, 5/80mg, 10/10mg, 10/20mg, 10/40mg, 10/80mgTab, Remodulin 1mg/ml, 2.5mg/ml, 5mg/ml, 10mg/ml Solution.
Special Authorization - Revised Criteria: Zyprexa 2.5mg, 5mg, 7.5mg, 10mg, 15mg Tab. Zyprexa Zydis 5mg, 10mg, Tab.
Drugs reviewed And Not Listed: Diamicor MR 30mg Tab, Levemir 100 units/ml Penfill Cart, Macugen 0.3mg/90ul Prefilled Syringe, Somavert 10mg, 15mg, 20mg Vial, Lyrica 25mg, 50mg, 75mg, 150mg, 300mg, Cap.
No Longer Requires Special Authorization: Norvasc 5mg, 10mg Tab.
Posted February 26, 2007
Nova Scotia
NS Pharmacare Bulletin Feb 2007 - Volume 07-02
Highlights
Delisted: Apo-Triazo 0.125mg, 0.25mg;
18 Delisted Muscle Relaxants (see bulletin) New Products: Altace 15mg Tab; Alvesco 100mcg/dose, 200mcg/dose inh; Duragesic 12mcg/hr patch; Linessa 21 & 28 day.
Change in benefit status from Exception to Full Benefit: All Lamotrigine products previously listed in Nova Scotia.
Criteria Changes: Peginterferon Alfa-2A; Singulair
Posted February 21, 2007
Manitoba
Manitoba Bulletin #55 effective March 15, 2007
Highlights
Part 1 Additions: Apo-Cilazapril/HCTZ 5mg/12.5mg Tab; Apo-Digoxin 0.0635mg, 0.125mg, 0.25mg Tab; Apo-Medroxy 10mg Tab; Apo-Ondansetron 4mg, 8mg Tab; Apo-Ranitidine 15mg/ml O/L; Fenomax 160mg Cap; Kaletra 200mg/50mg Tab; Novo-Acyclovir 200mg, 400mg 800mg Tab; Novo-Pramipexole 0.25mg, 0.5mg, 1mg, 1.5mg Tab; pms-Digoxin 0.0635mg, 0.125mg, 0.25mg Tab; pms-famciclovir 125mg, 250mg, 500mg Tab; pms-Hydrochlorothiazide 12.5mg Tab; pms-Pramipexole 0.25mg, 0.5mg, 1mg, 1.5mg Tab; ratio-Bupropion SR 100mg, 150mg Tab; Sandoz Carbamazepine 100mg, 200mg Chew Tab; Sandoz Carbamazepine CR 200mg, 400mg Tab; Sandoz Diclofenac 25mg, 50mg Tab; Sandoz Diclofenac SR 75mg, 100mg Tab SR; Sandoz Fenofibrate S 100mg, 160mg Tab; Sandoz Pindolol 5mg, 10mg, 15mg Tab; Sandoz Terbinafine 250mg Tab.
Part 2 Addition: Novo-Sumatriptan DF 50mg, 100mg Tabs;
Part 3 Additions: Apo-Levetiracetam 250mg, 500mg, 750mg Tab; pms-Alendronate FC 70mg Tab; pms-Leflunomide 10mg, 20mg Tab; Sandoz Alendronate 5mg, 10mg, 70mg Tabs; Sandoz Calcitonin 200IU Nas Spray; Sandoz Diclofenac Rapide 50mg Tab.
Not Recommended: Altace Plus Felodipine, Amevive, Enablex, Forteo, Fosavance, Lyrica, Macugen, Somavert, Niaspan PravASA.
Posted February 9, 2007
Manitoba
Manitoba Bulletin #54 effective Feb 9, 2007
Highlights
Additions (moved from part 3): Avandia 2mg, 4mg, 8mg Tab; Novo-Bupropion SR, 150mg Tab; Sandoz Bupropion SR 10mg, 150mg Tab; Wellbutrin SR 100mg, 150mg Tab; Wellbutrin XL 150mg, 300mg Tab.
Posted February 6, 2007
Québec
Modification #20 - Feb 7, 2007 & Quebec capsule Feb 2007
Highlights
Additions: Linessa .025mg/.100mg, .025mg/.150mg Tabs
Exception Drug Additions: Aptivus 250mg Cap; Azilects .5mg, 1mg Tabs; Baraclude .5mg Tab, .05mg/ml Oral Sol; Prezista 300mg Tab; Revatio 20mg Tab; Uromax 10mg, 15mg Tab LA; Vesicare 5mg 10mg Tab.Transfer to
Full Benefit: Norprolac 75mcg, 150mcg Tab.
Refused due to therapeutic value: Biphentin, Denavir, Orencia, Rituxan, Tracleer.
Refused due to price: Remicade.
Change in criteria: Serc, Novo-Betahistine, Pegasys RBV; Pegetron, Pegetron Redipen; Macugen, Marinol, Avonex, Betaseron, Copaxone, Rebif.
Posted February 5, 2007
Nova Scotia
NS Pharmacare Bulletin Jan 2007 - Volume #07-01
Highlights
Changes to Criteria Codes outlined; New Products: Aranesp 25mcg/ml inj; 40mcg/ml; 100mcg/ml, 200mcg/ml; 500mcg/ml inj sol;
Not Insured: NuvaRing; Wellbutrin XL 150mg, 300mg Tab
Discontinued Products: Total of 185 products discontinuation - see update for list.
Posted February 3, 2007
Québec
Le Choix des médicaments assurés au Québec
Highlights
See list for details.
Posted January 24, 2007
Newfoundland
Newfoundland Interchangeable Formulary Jan 18, 2007
Highlights |
